Vikash Titwade
About Vikash Titwade
Data last updated:
Vikash Titwade is a Director at Milan Medicare Private Limited (since 2025). The companies operate in Healthcare and Trading. Milan Medicare Private Limited reported revenue of ₹14.26 Cr (FY 2025). Earlier, Vikash Titwade was a Director at Liveliness Healthcare Private Limited (2018–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Milan Medicare Private Limited U33100MP2022PTC062592 | Director | 10 Jan 2025 | 2022 | ₹14.26 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Liveliness Healthcare Private Limited U51909MP2018PTC046517 | Director | 11 Sep 2018 | 2018 | ₹7 Lakh (FY 2022) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vikash Titwade
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vishesh Shrivastav | 10429705 | Milan Medicare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vikash Titwade
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vikash Titwade
Vikash Titwade currently holds 1 directorship: Milan Medicare Private Limited (Director, since 10 Jan 2025, revenue ₹14.26 Cr (FY 2025)).
Vikash Titwade was first appointed on 11 Sep 2018 as Director at Liveliness Healthcare Private Limited. The most recent appointment on record is 10 Jan 2025 at Milan Medicare Private Limited.
Vikash Titwade held 1 earlier board appointment: Liveliness Healthcare Private Limited (Director, 11 Sep 2018 to 23 Feb 2019).
The current boards of Vikash Titwade's companies include Vishesh Shrivastav (Milan Medicare Private Limited).